Advancements in complement inhibition for PNH and primary complement–mediated thrombotic microangiopathy
Abstract: Paroxysmal nocturnal hemoglobinuria (PNH) and primary complement–mediated thrombotic microangiopathy, also known as atypical hemolytic uremic syndrome (aHUS), are hematologic disorders characterized by dysregulation of the complement system leading to hemolysis and other systemic and poten...
Saved in:
Main Authors: | Thalia Padilla Kelley, Hannah King, Aditya Malhotra, Thomas G. DeLoughery, Kylee Martens, Joseph J. Shatzel |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-08-01
|
Series: | Blood Advances |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2473952925002873 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Von Willebrand Factor-Mediated Thrombotic Microangiopathies
by: Gennaro, Leonardo Di, et al.
Published: (2012) -
COVID-19 and thrombotic microangiopathy
by: E. V. Sluhanchuk, et al.
Published: (2022-01-01) -
THROMBOTIC MICROANGIOPATHY IN THE PATHOGENESIS OF OBSTETRIC COMPLICATIONS
by: S. V. Akinshina, et al.
Published: (2016-06-01) -
Transplant-Associated Thrombotic Microangiopathy in Childhood
by: Erbey, Fatih
Published: (2012) -
Plasmin Cascade Mediates Thrombotic Events in SARS-CoV-2 Infection via Complement and Platelet-Activating Systems
by: Kavitha Mukund, et al.
Published: (2020-01-01)